6-K ·Filed Jun 18, 2026

KMDA

KAMADA LTD
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago SEC0001213900-26-069852
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine proxy filing for an annual meeting with no earnings or operational news. The ISO share pool increase is immaterial. Monitor for any future 6-K or 20-F filing that may contain financial results or guidance updates.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
KMDA ▲ +13.68% at T+60d
NEUTRAL call ✓ call won +13.68% · α vs SPY +11.79% · entry $7.31 → $8.31
Entry anchored
Jun 17, 03:58 PM ET
via exchange tick
T+1d
-1.64%
call -1.64% · α -1.33%
$7.19
settled 3mo ago
T+5d
-1.78%
call -1.78% · α -0.11%
$7.18
settled 3mo ago
T+20d
-5.47%
call -5.47% · α -6.00%
$6.91
settled 3mo ago
T+60d
+13.68%
call +13.68% · α +11.79%
$8.31
settled 18d ago

Price Chart

Loading chart...

Executive Summary

Kamada Ltd. filed a 6-K on June 18, 2026, providing notice of its Annual General Meeting of Shareholders to be held on August 5, 2026. The meeting will cover routine director re-elections, approval of option grants to directors, an amendment to increase the ISO share reserve under the U.S. Taxpayers Appendix by 50,000 shares (to 550,000), and ratification of auditor EY. The filing also includes beneficial ownership data showing FIMI Funds (38.28%) and insiders (46.42%) as major holders. No financial results or material operational changes are disclosed.

Key Facts

  • AGM scheduled for August 5, 2026, with record date June 23, 2026
  • Proposal to increase ISO reserve under U.S. Taxpayers Appendix from 500,000 to 550,000 ordinary shares
  • Options to purchase 30,000 ordinary shares proposed for each director nominee at exercise price NIS 22.87
  • FIMI Opportunity Funds beneficially own 22,084,287 shares (38.28%) as of May 31, 2026
  • Directors and executive officers as a group beneficially own 27,252,278 shares (46.42%)
  • Audit fees for 2025: $420,000; total fees paid to EY: $514,226

Financial Impact

No material financial impact from this filing; the ISO share increase is a routine plan amendment with minimal dilution (50,000 shares on 57.7M outstanding, ~0.09% dilution)

dilution

Risk Factors

  • No material risks identified in this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-069852
Document: ea029492701ex99-2.htm0001213900-26-069852
Document: ea0294927-6k_kamada.htm0001213900-26-069852
Document: 0001213900-26-069852-index-headers.html0001213900-26-069852
Document: 0001213900-26-069852-index.html0001213900-26-069852
Document: 0001213900-26-069852.txt0001213900-26-069852
18 reports for KMDA
Performance horizon
100% Hit rate 8 of 8 directional calls best @ T+20▲ +16.13%Aug 12, 2026
Filters
Rows
Reports for KMDA — sortable, filterable
TypeNow
Sep 16, 2026
16d ago
EFFECT
NEUTRAL ★ 3/10
$8.19 $8.77▲ +7.08%▲ +4.52%$8.20 (+0.12%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$7.99 $8.67▲ +8.51%▲ +9.01%$8.20 (+2.63%)
Sep 3, 2026
29d ago
Press Release
NEUTRAL ★ 2/10
$8.54 $8.31▼ −2.69%▼ −1.48%$8.20 (−3.98%)
Sep 3, 2026
29d ago
6-K
NEUTRAL ★ 2/10
$8.54 $8.31▼ −2.69%▼ −1.48%$8.20 (−3.98%)
Aug 17, 2026
6w ago
6-K / PRESS-RELEASE
BULLISH ★ 6/10
$7.76 $8.43▲ +8.63%▲ +9.82%$8.20 (+5.67%)
Aug 12, 2026
7w ago
6-K
BULLISH ★ 6/10
$6.88 $7.89▲ +14.68%▲ +15.12%$8.20 (+19.19%)
Aug 5, 2026
8w ago
6-K
NEUTRAL ★ 2/10
$7.14 $7.26▲ +1.68%▲ +0.47%$8.20 (+14.85%)
Aug 5, 2026
8w ago
6-K
NEUTRAL ★ 2/10
$7.18 $6.88▼ −4.18%▼ −4.53%$8.20 (+14.21%)
Jul 20, 2026
10w ago
6-K
BULLISH ★ 6/10
$7.09 $7.06▼ −0.42%▲ +0.00%$8.20 (+15.66%)
Jul 13, 2026
11w ago
6-K
NEUTRAL ★ 3/10
$7.17 $7.05▼ −1.67%▼ −0.89%$8.20 (+14.37%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (36h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access